A Combination of α-Fetoprotein and Des-γ-Carboxy Prothrombin Is Superior in Detection of Hepatocellular Carcinoma

@article{Ertle2013ACO,
  title={A Combination of $\alpha$-Fetoprotein and Des-$\gamma$-Carboxy Prothrombin Is Superior in Detection of Hepatocellular Carcinoma},
  author={Judith Ertle and Dominik Heider and Marc Wichert and Benedikt Keller and Robert Kueper and Philip Hilgard and Guido Gerken and Joerg Friedrich Schlaak},
  journal={Digestion},
  year={2013},
  volume={87},
  pages={121 - 131}
}
Background and Aim: The incidence of hepatocellular carcinoma (HCC) is increasing in western countries. Despite its low sensitivity, the diagnosis of HCC still depends on detection of α-fetoprotein (AFP). Therefore, the aim of this study was to evaluate the combined analysis of AFP and des-γ-carboxy prothrombin (DCP) in a European cohort. Methods: We performed a single-center study (164 HCC/422 controls), in which the serum concentrations of AFP and DCP were determined. Results: AFP and DCP… 

Figures and Tables from this paper

Alpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks after interferon-based therapy predict hepatocellular carcinoma development.
TLDR
It is suggested that the elevation of AFP and DCP levels at 24 wk after the completion of IFN and ribavirin therapy were strongly associated with the incidence of HCC irrespective of virological response among Japanese LC-C patients.
Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma
TLDR
The combined use of AFP, DKK1, and OPN as a biomarker panel could enhance the diagnostic ability for HCC.
Diagnostic accuracy of des‐gamma‐carboxy prothrombin for hepatocellular carcinoma in a French cohort using the Lumipulse® G600 analyzer
TLDR
It is concluded that DCP outperformed AFP for the detection of HCC, in comparison with alpha‐fetoprotein in a French cohort using a new analyser.
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection.
TLDR
PIVKA II, when combined with AFP, may be considered as a screening test for HCC due to its high negative predictive value.
A Systematic Review of Des-γ-Carboxy Prothrombin for the Diagnosis of Primary Hepatocellular Carcinoma
TLDR
DCP has moderate diagnostic utility for PHC, although the above conclusion requires further support from additional high-quality studies.
Diagnostic value of prothrombin induced by the absence of vitamin K or antagonist-II (PIVKA-II) for early stage HBV related hepatocellular carcinoma
TLDR
Serum PIVka-II level is a potential marker for early diagnosis of HCC and microvascular invasion and the use of PIVKA-II may improve assessment of tumor prognosis and guide development of therapeutic strategy.
Performance of Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) for Hepatocellular Carcinoma Screening in Chinese Population
TLDR
PIVKA-II was as efficient as AFP when used as a single marker for HCC screening and the combination of two biomarkers gave a better performance.
PIVKA-II as a Potential New Biomarker for Hepatocellular Carcinoma – A Pilot Study
TLDR
PIVKA-II achieved better clinical sensitivity than AFP and the difference in this sensitivity was statistically significant and the recommendation is for addition of PIVka-II to the routine panel of HCC tumour markers.
Evaluation of Diagnostic Efficiency of Alpha-Fetoprotein in Patients with Liver Cirrhosis and Hepatocellular Carcinoma: Single-Center Experience
TLDR
The size of the surface below the ROC curve (AUC) was 0.877 (0.80-0.95), which makes AFP a good biomarker and this diagnostic test is sufficient to separate patients with HCC and LC.
...
...

References

SHOWING 1-10 OF 37 REFERENCES
Prognostic and diagnostic value of des-γ-carboxy prothrombin in liver cancer.
TLDR
The data presented above demonstrate the importance of DCP in formulating a prognosis for patients with HCC, and the specificity of the DCP assay appears to be superior to that of AFP.
Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.
TLDR
AFP was more sensitive than DCP and AFP-L3% for the diagnosis of early and very early stage HCC at a new cutoff of 10.9 ng/mL.
A study about mechanisms of des-gamma-carboxy prothrombin's production in hepatocellular carcinoma.
TLDR
DCP detectable serum levels are the result not only of vitamin K deficiency or selective defects of carboxylase, but probably alterations of membrane receptors or cytoplasmatic transfers, that are necessary for the function of Vitamin K, are involved.
Des‐gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients
TLDR
Evaluated whether DCP is more sensitive and specific than AFP for differentiating HCC from nonmalignant chronic liver disease in a cohort of American patients from a single referral center found it to be so, and the role of DCP in early HCC is underway.
α-fetoprotein and ultrasonography screening for hepatocellular carcinoma
TLDR
Pathology assessment of liver explants in living-donor transplantation programs will provide more precise and reliable information regarding the value of AFP and US as HCC screening tools.
Frequency of Elevated Hepatocellular Carcinoma (HCC) Biomarkers in Patients With Advanced Hepatitis C
TLDR
Mild–moderate elevations in total AFP and DCP but not in AFP-L3 occur frequently in patients with chronic hepatitis C and advanced fibrosis, are related to factors other than HCC, and are poor predictors of HCC.
Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma.
TLDR
Levels of the abnormal prothrombin were low in patients with chronic active hepatitis or metastatic carcinoma involving the liver, and undetectable in normal subjects, and may be useful in the laboratory diagnosis of primary hepatocellular carcinoma.
Diagnostic accuracy of α‐fetoprotein and des‐γ‐carboxy prothrombin in screening for hepatocellular carcinoma in liver transplant candidates
TLDR
This study aimed to evaluate the accuracy of AFP and DCP measurement for the diagnosis of HCC in liver transplant candidates.
Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma.
TLDR
Pathology assessment of liver explants in living-donor transplantation programs will provide more precise and reliable information regarding the value of AFP and US as HCC screening tools.
Hepatocellualar carcinoma serum markers.
TLDR
Several biomarkers have been proposed as markers for the early detection of HCC and their mechanisms of production, and their diagnostic and prognosis roles are described.
...
...